UFC Transfers Patent and Tilapia Skin Dressing Will Arrive at Hospitals with Industrial Production Expected to Start by 2027.
The industrial production of the innovative biological dressing made with tilapia skin is set to transform burn treatment in Brazil.
This advancement is made possible because UFC (Federal University of Ceará) has transferred the patent of the technology for commercial use.
The technology, developed within the university since 2015, will now be managed by the pharmaceutical industry, in a move that solidifies the partnership between academia and the productive sector.
-
Processors can become 1,000 times faster with a new device that uses light pulses, operates in 40 picoseconds, and reduces the heat that stalls data centers.
-
Noise in the sky frightened residents: NASA confirms that a meteor exploded over New England with a force equivalent to 230 tons of TNT
-
The invisible flaw that protects banks, passwords, and messages may be numbered after a quantum experiment transforms imperfect randomness into numbers impossible to predict.
-
China has ceased to be just a factory for cheap products and now challenges health giants: Chinese laboratories are advancing in medicines, while other countries recalculate their medical dependence.
Patent Transferred and Tilapia Skin Dressing Will Reach Hospitals Nationwide
The decision to transfer the patent ensures the industrial and commercial use of the technology, something considered essential by UFC researchers.
The dressing made with tilapia skin is expected to finally reach hospitals and specialized centers, expanding access to treatments that have already shown significant results in controlled studies.
Biotec Wins Public Bid and Begins Plan to Industrialize the Dressing
The winning company of the licensing process was Biotec, a pharmaceutical company with 32 years of experience and direct support for research since 2018.
The technology also has applications in other types of injuries, such as vaginal reconstructions for patients undergoing radiotherapy.
University Transfers Patent and Tilapia Skin Dressing Will Arrive at Hospitals with Million-Unit Production
With the signing of the agreement, UFC and the inventors of the method will receive R$ 850,000, in addition to 3.7% royalties on the factory’s net profit.
The initial projection from Biotec indicates the production of 1 million units of tilapia skin in the first year.
Factory Expected to Begin Operations by the End of 2027
Biotec estimates that the factory will start operations by the end of 2027, after completing construction and setting up the industrial plant.
With this new phase, experts believe that Brazil will establish itself as a global reference in the use of tilapia skin for clinical purposes.

Be the first to react!